$114.97
00.00%
Pre-Market: Jul 19, 5:08 PM EDT
15 minutes delayed
Comments
Loading...
Blueprint Medicines
BPMCNASDAQ
Blueprint Medicines (NASDAQ:BPMC) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/05/2023 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $200.00M | $200.00M | $199.69M | Get Alert |
| 11/01/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $200.00M | $200.00M | $191.21M | Get Alert |
| 08/02/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $194.85M | Get Alert |
| 05/03/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $192.34M | Get Alert |
| 02/16/2022 | BPMC | Blueprint Medicines | FY | 2022 | — | — | — | $180.00M | $200.00M | $210.91M | Get Alert |
| 01/10/2022 | BPMC | Blueprint Medicines | FY | 2021 | — | — | — | $180.00M | $180.00M | $173.16M | Get Alert |
| 10/28/2021 | BPMC | Blueprint Medicines | FY | 2021 | — | — | — | $170.00M | $180.00M | $148.37M | Get Alert |
FAQ
What is the most recent guidance for Blueprint Medicines (BPMC)?
There have been no specific sales or earnings guidance reported for Blueprint Medicines in recent months.
Browse guidance and forecast on all stocks.